Abstract：
BACKGROUND: Treating multiple myeloma is complex, and providing supportive care through an interdisciplinary approach is essential.
OBJECTIVE: To report and synthesize pharmacists\' clinical activities and impact on the care of patients with multiple myeloma.
METHODS: This was a scoping review that followed the PRISMA-ScR reporting recommendations. A search was conducted in PubMed, Embase, Web of Science, Scopus, and LILACS from the inception of the database until January 10th, 2024. Papers that reported pharmacists\' clinical activities in the care of patients with multiple myeloma were included. Descriptive Elements of Pharmacist Intervention Characterization Tool (DEPICT) version 2 was used to characterize the pharmacists\' clinical activities. The results are presented as a narrative and tabular synthesis.
RESULTS: A total of 2885 records were identified, 10 of which met the inclusion criteria. Pharmacists\' clinical activities related to \'direct patient care\' (n = 8) and \'medication counseling, education, and training\' (n = 7) were the most cited. Most were provided for patients (n = 8), by one-on-one contact (n = 9), and through face-to-face communication method (n = 8), with patient counseling being the main action taken by pharmacists (n = 7). Materials that supported pharmacists\' actions were cited in five studies. Integrating pharmacists into interdisciplinary teams led to improved process, clinical, humanistic, and economic outcomes.
CONCLUSIONS: This scoping review emphasizes pharmacists\' clinical activities in improving the care of patients with multiple myeloma. There is a need to develop studies with patient-reported outcomes and comprehensive reporting of pharmacists\' clinical activities to ensure reproducibility and effective implementation in clinical practice.
OBJECTIVE: To report and synthesize pharmacists\' clinical activities and impact on the care of patients with multiple myeloma.
METHODS: This was a scoping review that followed the PRISMA-ScR reporting recommendations. A search was conducted in PubMed, Embase, Web of Science, Scopus, and LILACS from the inception of the database until January 10th, 2024. Papers that reported pharmacists\' clinical activities in the care of patients with multiple myeloma were included. Descriptive Elements of Pharmacist Intervention Characterization Tool (DEPICT) version 2 was used to characterize the pharmacists\' clinical activities. The results are presented as a narrative and tabular synthesis.
RESULTS: A total of 2885 records were identified, 10 of which met the inclusion criteria. Pharmacists\' clinical activities related to \'direct patient care\' (n = 8) and \'medication counseling, education, and training\' (n = 7) were the most cited. Most were provided for patients (n = 8), by one-on-one contact (n = 9), and through face-to-face communication method (n = 8), with patient counseling being the main action taken by pharmacists (n = 7). Materials that supported pharmacists\' actions were cited in five studies. Integrating pharmacists into interdisciplinary teams led to improved process, clinical, humanistic, and economic outcomes.
CONCLUSIONS: This scoping review emphasizes pharmacists\' clinical activities in improving the care of patients with multiple myeloma. There is a need to develop studies with patient-reported outcomes and comprehensive reporting of pharmacists\' clinical activities to ensure reproducibility and effective implementation in clinical practice.
摘要：
背景：多发性骨髓瘤的治疗是复杂的，通过跨学科方法提供支持性护理至关重要。
目的：报告并综合药师的临床活动及其对多发性骨髓瘤患者护理的影响。
方法：这是一个遵循PRISMA-ScR报告建议的范围审查。在PubMed进行了搜索，Embase,WebofScience,Scopus,和LILACS从数据库开始到1月10日，2024.包括报告药剂师在多发性骨髓瘤患者护理中的临床活动的论文。药剂师干预表征工具（DEPICT）版本2的描述性要素用于表征药剂师的临床活动。结果以叙述和表格形式综合显示。
结果：共确定了2885条记录，其中10个符合纳入标准。药剂师与“直接患者护理”（n=8）和“药物咨询”相关的临床活动，教育,和培训(n=7)被引用最多的。大多数为患者提供（n=8），通过一对一接触(n=9)，通过面对面的交流方式(n=8)，患者咨询是药剂师采取的主要行动（n=7）。支持药剂师行动的材料在五项研究中被引用。将药剂师融入跨学科团队导致改进流程，临床,人文,和经济结果。
结论：本综述强调药师在改善多发性骨髓瘤患者护理方面的临床活动。有必要开展具有患者报告结果和药剂师临床活动综合报告的研究，以确保在临床实践中的可重复性和有效实施。
目的：报告并综合药师的临床活动及其对多发性骨髓瘤患者护理的影响。
方法：这是一个遵循PRISMA-ScR报告建议的范围审查。在PubMed进行了搜索，Embase,WebofScience,Scopus,和LILACS从数据库开始到1月10日，2024.包括报告药剂师在多发性骨髓瘤患者护理中的临床活动的论文。药剂师干预表征工具（DEPICT）版本2的描述性要素用于表征药剂师的临床活动。结果以叙述和表格形式综合显示。
结果：共确定了2885条记录，其中10个符合纳入标准。药剂师与“直接患者护理”（n=8）和“药物咨询”相关的临床活动，教育,和培训(n=7)被引用最多的。大多数为患者提供（n=8），通过一对一接触(n=9)，通过面对面的交流方式(n=8)，患者咨询是药剂师采取的主要行动（n=7）。支持药剂师行动的材料在五项研究中被引用。将药剂师融入跨学科团队导致改进流程，临床,人文,和经济结果。
结论：本综述强调药师在改善多发性骨髓瘤患者护理方面的临床活动。有必要开展具有患者报告结果和药剂师临床活动综合报告的研究，以确保在临床实践中的可重复性和有效实施。
